Patent · US Active

Dosimetry assessment method and system for organ at risk in esophageal radiotherapy plan

US11515025B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 4, 2020
Grant dateNov 29, 2022
Priority date
Expiry dateMar 4, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG06T2207/10081
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

A dosimetry assessment method for an organ at risk (OAR) in an esophageal radiotherapy plan includes: acquiring volumetric-modulated arc therapy (VMAT) plan data of a patient with esophageal cancer, and obtaining a distance-target histogram (DTH); subjecting a geometric feature vector of the DTH to dimension reduction to obtain a dimension-reduced geometric feature vector; establishing a deep belief network (DBN) model, and completing training the DBN model; non-linearly fitting a correlation between a dose feature vector and the dimension-reduced geometric feature vector to obtain a dose feature vector with a dimension being identical to a dimension of the dimension-reduced geometric feature vector; and reconstructing the dose feature vector through a decoding layer of an autoencoder structure to obtain a dose feature vector with a dimension being identical to a dimension of the geometric feature vector before the dimension reduction, and finally obtaining a dose-volume histogram (DVH) for predicting the OAR.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.